- Home
- MDGL vs FNB Comparison
MDGL vs FNB Comparison
Compare MDGL & FNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- FNB
- Stock Information
- Founded
- MDGL 2011
- FNB 1864
- Country
- MDGL United States
- FNB United States
- Employees
- MDGL N/A
- FNB N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- FNB Major Banks
- Sector
- MDGL Health Care
- FNB Finance
- Exchange
- MDGL Nasdaq
- FNB Nasdaq
- Market Cap
- MDGL 6.4B
- FNB 5.6B
- IPO Year
- MDGL N/A
- FNB N/A
- Fundamental
- Price
- MDGL $340.14
- FNB $15.52
- Analyst Decision
- MDGL Buy
- FNB Buy
- Analyst Count
- MDGL 14
- FNB 5
- Target Price
- MDGL $351.67
- FNB $18.60
- AVG Volume (30 Days)
- MDGL 392.5K
- FNB 2.3M
- Earning Date
- MDGL 02-26-2025
- FNB 01-22-2025
- Dividend Yield
- MDGL N/A
- FNB 3.10%
- EPS Growth
- MDGL N/A
- FNB N/A
- EPS
- MDGL N/A
- FNB 1.27
- Revenue
- MDGL $76,813,000.00
- FNB $1,517,062,000.00
- Revenue This Year
- MDGL N/A
- FNB N/A
- Revenue Next Year
- MDGL $195.95
- FNB $4.60
- P/E Ratio
- MDGL N/A
- FNB $12.21
- Revenue Growth
- MDGL N/A
- FNB 1.19
- 52 Week Low
- MDGL $168.25
- FNB $12.49
- 52 Week High
- MDGL $368.29
- FNB $17.70
- Technical
- Relative Strength Index (RSI)
- MDGL 61.81
- FNB 54.04
- Support Level
- MDGL $266.44
- FNB $15.36
- Resistance Level
- MDGL $343.97
- FNB $16.09
- Average True Range (ATR)
- MDGL 20.88
- FNB 0.39
- MACD
- MDGL 2.00
- FNB 0.15
- Stochastic Oscillator
- MDGL 92.59
- FNB 71.95
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.
About FNB F.N.B. Corporation
F N B Corp provides a full range of financial services, principally to consumers, corporations, governments and small- to medium-sized businesses. It has three reportable business segments: Community Banking, Wealth Management and Insurance. The majority of revenue is from the Community banking segment. It offers commercial & consumer banking services. Commercial banking solutions include corporate banking, small business banking, investment real estate financing, business credit, capital markets & lease financing. Consumer banking products & services include deposit products, mortgage lending, & consumer lending & a complete suite of mobile & online banking services.